GNMX
Legal & General Group’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-7,674
| Closed | -$15K | – | 3413 |
|
|
2017
Q1 | $15K | Hold |
7,674
| – | – | ﹤0.01% | 3146 |
|
|
2016
Q4 | $40K | Buy |
7,674
+3,114
| +68% | +$16.2K | ﹤0.01% | 2941 |
|
|
2016
Q3 | $24K | Hold |
4,560
| – | – | ﹤0.01% | 2786 |
|
|
2016
Q2 | $25K | Buy |
+4,560
| New | +$25K | ﹤0.01% | 2805 |
|
|
2014
Q4 | – | Sell |
-255,193
| Closed | -$1.33M | – | 2672 |
|
|
2014
Q3 | $1.33M | Sell |
255,193
-194,807
| -43% | -$1.01M | ﹤0.01% | 962 |
|
|
2014
Q2 | $3.56M | Hold |
450,000
| – | – | ﹤0.01% | 767 |
|
|
2014
Q1 | $3.06M | Sell |
450,000
-275,000
| -38% | -$1.87M | ﹤0.01% | 770 |
|
|
2013
Q4 | $4.29M | Hold |
725,000
| – | – | 0.01% | 712 |
|
|
2013
Q3 | $5.34M | Hold |
725,000
| – | – | 0.01% | 695 |
|
|
2013
Q2 | $2.83M | Buy |
+725,000
| New | +$2.83M | ﹤0.01% | 735 |
|